Literature DB >> 24681950

A novel mechanism for the control of translation of specific mRNAs by tumor suppressor protein Pdcd4: inhibition of translation elongation.

A Biyanee1, J Ohnheiser2, P Singh2, K-H Klempnauer2.   

Abstract

The tumor suppressor gene Pdcd4 (programmed cell death gene 4) has drawn considerable attention because its downregulation is involved in the development of several types of cancer. Because Pdcd4 interacts with the translation initiation factor eIF4A and inhibits its helicase activity, Pdcd4 has been implicated in the translational suppression of cellular mRNAs containing structured 5'-untranslated regions. However, Pdcd4's role in translation regulation is still poorly understood, because only very few physiological Pdcd4 target mRNAs are known. By using a Pdcd4-deficient clone of the chicken B-cell line DT40, we have discovered that the mRNA of the A-myb proto-oncogene is a novel Pdcd4 target RNA whose translation is suppressed by Pdcd4. Interestingly, the inhibitory effect of Pdcd4 is independent of the Pdcd4-eIF4A interaction, but is dependent on an RNA-binding domain at the N terminus of Pdcd4 and on sequences located within the coding region of A-myb mRNA, indicating that Pdcd4 suppresses A-myb translation by a novel mechanism. Our data show that the Pdcd4 RNA-binding domain preferentially recognizes an RNA secondary structure element formed by the part of the A-myb coding region that mediates Pdcd4-dependent suppression. Previously, we have shown that Pdcd4 also suppresses the translation of the c-myb mRNA by a similar mechanism involving binding of Pdcd4 to RNA secondary structure formed by the c-myb coding region. Surprisingly, our data show that Pdcd4 exerts its inhibitory activity only when the target region of Pdcd4 in A-myb and c-myb mRNA is itself translated, consistent with a mechanism in which Pdcd4 suppresses translation by interfering with translation elongation. Taken together, our work reveals a novel mechanism by which Pdcd4 affects the translational of cellular RNAs. Furthermore, as c-myb and A-myb are members of the Myb proto-oncogene family whose deregulation has been implicated in tumorigenesis, inhibiting their translation might contribute to the tumor-suppressive activity of Pdcd4.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24681950     DOI: 10.1038/onc.2014.83

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

Review 1.  The role of Pdcd4 in tumour suppression and protein translation.

Authors:  Qing Wang; Hsin-Sheng Yang
Journal:  Biol Cell       Date:  2018-05-28       Impact factor: 4.458

2.  Programmed cell death 4 and BCR-ABL fusion gene expression are negatively correlated in chronic myeloid leukemia.

Authors:  Xia Zhang; Riming Liu; Baohua Huang; Xiaolu Zhang; Weijuan Yu; Cuixia Bao; Jie Li; Chengming Sun
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

3.  Programmed cell death 4 mechanism of action: The model to be updated?

Authors:  Polina N Vikhreva; Svetlana V Kalinichenko; Igor V Korobko
Journal:  Cell Cycle       Date:  2017-08-30       Impact factor: 4.534

4.  Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis.

Authors:  Pedro M Rodrigues; Marta B Afonso; André L Simão; Pedro M Borralho; Cecília M P Rodrigues; Rui E Castro
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

5.  CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation.

Authors:  Antonio Pisano; Simona Ceglia; Camillo Palmieri; Eleonora Vecchio; Giuseppe Fiume; Annamaria de Laurentiis; Selena Mimmi; Cristina Falcone; Enrico Iaccino; Annarita Scialdone; Marilena Pontoriero; Francesca Fasanella Masci; Rosanna Valea; Shibu Krishnan; Marco Gaspari; Giovanni Cuda; Giuseppe Scala; Ileana Quinto
Journal:  J Biol Chem       Date:  2015-04-16       Impact factor: 5.157

6.  RNA-binding protein HuR sequesters microRNA-21 to prevent translation repression of proinflammatory tumor suppressor gene programmed cell death 4.

Authors:  D K Poria; A Guha; I Nandi; P S Ray
Journal:  Oncogene       Date:  2015-07-20       Impact factor: 9.867

7.  An evolutionarily conserved interaction of tumor suppressor protein Pdcd4 with the poly(A)-binding protein contributes to translation suppression by Pdcd4.

Authors:  Olesja Fehler; Priyanka Singh; Astrid Haas; Diana Ulrich; Jan P Müller; Johanna Ohnheiser; Karl-Heinz Klempnauer
Journal:  Nucleic Acids Res       Date:  2014-09-04       Impact factor: 16.971

8.  Translation, Pdcd4 and eIF4A.

Authors:  Abhiruchi Biyanee; Priyanka Singh; Karl-Heinz Klempnauer
Journal:  Oncoscience       Date:  2015-08-10

9.  Depletion of the mRNA translation initiation inhibitor, programmed cell death protein 4 (PDCD4), impairs L6 myotube formation.

Authors:  Naomi Maeda; Abdikarim Abdullahi; Brendan Beatty; Zameer Dhanani; Olasunkanmi A J Adegoke
Journal:  Physiol Rep       Date:  2017-09

10.  4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.

Authors:  Tommaso De Marchi; Ning Qing Liu; Cristoph Stingl; Mieke A Timmermans; Marcel Smid; Maxime P Look; Mila Tjoa; Rene B H Braakman; Mark Opdam; Sabine C Linn; Fred C G J Sweep; Paul N Span; Mike Kliffen; Theo M Luider; John A Foekens; John W M Martens; Arzu Umar
Journal:  Mol Oncol       Date:  2015-08-07       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.